XIENCE PRIME Adverse Events: FDA MAUDE Data

ABBOTT VASCULAR INC. · Coronary Drug-Eluting Stent · First cleared Oct 2012 · 10 device variants grouped

Total Reports

1,192

Reports (30d)

5

Active Signals

0

Open Recalls

0

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

Post-Market Clinical Evaluation Findings

evaluation report, polymer, clinical follow, market clinical, post market

4

reports

2

Balloon Retrieval Difficulty and Shaft Break

synergy, delivery, selected, shaft, synergy drug

1

reports

3

Proximal Edge Dissection During Implant

delay procedure, treat, provided procedure, procedure additional, significant delay

1

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.